J N Winter - JoVE Visualize

Showing results (21-30 of 54) with videos related to

Pageof 6

Sort By:

The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994

Decreased intracellular compartmentalization of doxorubicin in cell lines expressing P-glycoproteinM S Dordal, M Jackson-Stone, A C Ho, et al.

International Journal of Cancer|March 12, 1993

P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell lineG Raghu, M Pierre-Jerome, M S Dordal, et al.

Cytotherapy|July 26, 2003

Ex-vivo expansion of CFU-GM and BFU-E in unselected PBMC cultures with Flt3L is enhanced by autologous plasmaM Guo, W M Miller, E T Papoutsakis, et al.

Cytometry|August 1, 1995

Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugsM S Dordal, A C Ho, M Jackson-Stone, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996

Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOML I Gordon, J Anderson, T M Habermann, et al.

Bone Marrow Transplantation|August 3, 2005

Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSFM Tomblyn, L I Gordon, S Singhal, et al.

Cancer Research|February 1, 1987

Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potentialA L Epstein, R J Marder, J N Winter, et al.

Cytotherapy|June 4, 2002

Clinical-scale production of granulocyte progenitor and post-progenitor cells using daniplestim, leridistim, Progenipoietin, Promegapoietin and autologous plasmaS D Patel, R Guo, W M Miller, et al.

American Journal of Clinical Pathology|April 1, 1986

Phenotypic analysis in diffuse, large cell lymphoma. Clinical and histologic associationsJ N Winter, R J Marder, W W Hauck, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000

Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology GroupH S Hochster, M M Oken, J N Winter, et al.

Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:

Pageof 6

The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994

Decreased intracellular compartmentalization of doxorubicin in cell lines expressing P-glycoproteinM S Dordal, M Jackson-Stone, A C Ho, et al.

International Journal of Cancer|March 12, 1993

P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell lineG Raghu, M Pierre-Jerome, M S Dordal, et al.

Cytotherapy|July 26, 2003

Ex-vivo expansion of CFU-GM and BFU-E in unselected PBMC cultures with Flt3L is enhanced by autologous plasmaM Guo, W M Miller, E T Papoutsakis, et al.

Cytometry|August 1, 1995

Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugsM S Dordal, A C Ho, M Jackson-Stone, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996

Phase I trial of dose escalation with growth factor support in patients with previously untreated diffuse aggressive lymphomas: determination of the maximum-tolerated dose of ProMACE-CytaBOML I Gordon, J Anderson, T M Habermann, et al.

Bone Marrow Transplantation|August 3, 2005

Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSFM Tomblyn, L I Gordon, S Singhal, et al.

Cancer Research|February 1, 1987

Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potentialA L Epstein, R J Marder, J N Winter, et al.

Cytotherapy|June 4, 2002

Clinical-scale production of granulocyte progenitor and post-progenitor cells using daniplestim, leridistim, Progenipoietin, Promegapoietin and autologous plasmaS D Patel, R Guo, W M Miller, et al.

American Journal of Clinical Pathology|April 1, 1986

Phenotypic analysis in diffuse, large cell lymphoma. Clinical and histologic associationsJ N Winter, R J Marder, W W Hauck, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000

Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology GroupH S Hochster, M M Oken, J N Winter, et al.

Pageof 6